SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
pharmaceutic
Journals
2
1
Journal of medical Internet research
2
BMJ (Clinical research ed.)
Research Groups
0
No Research Group Connected
Bibliographies
375
1
Results and Methodological Implications of the Digital Epidemiology of Prescription Drug References Among Twitter Users: Latent Dirichlet Allocation (LDA) Analyses.
2
When I use a word . . . Medical slang: gomers and gomerettes.
3
Genotoxicity of gold nanoparticles in the gilthead seabream (Sparus aurata) after single exposure and combined with the pharmaceutical gemfibrozil
4
In vitro anti-neoplastic activity of the ethno-pharmaceutical plant Hypericum adenotrichum Spach endemic to Western Turkey.
5
Combining Cellulose and Cyclodextrins: Fascinating Designs for Materials and Pharmaceutics.
6
Supramolecular pharmaceutical sciences: A novel concept combining pharmaceutical sciences and supramolecular chemistry
7
Generic selection criteria for safety and patient benefit [VIII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic diclofenac sodium tapes.
8
Possible use of a Nicotiana tabacum ‘Bright Yellow 2’ cell suspension as a model to assess phytotoxicity of pharmaceuticals (diclofenac)
9
Heterogeneous Fenton-like oxidation of pharmaceutical diclofenac by a catalytic iron-oxide ceramic microfiltration membrane
10
Removal of pharmaceuticals by powdered activated carbon adsorption: Effect of particle size and point of addition
11
The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership
12
Chemical profiling of Centaurea bornmuelleri Hausskn. aerial parts by HPLC-MS/MS and their pharmaceutical effects: From nature to novel perspectives.
13
Extraction and determination of trace amounts of three anticancer pharmaceuticals in urine by three-phase hollow fiber liquid-phase microextraction based on two immiscible organic solvents followed by high-performance liquid chromatography.
14
In Situ Characterization of Pharmaceutical Formulations by Dynamic Nuclear Polarization Enhanced MAS NMR.
15
Study of the state of readiness of pharmaceutical institutions of Ukraine for implementation of integrated quality systems
16
Research output of India compared to BRICS countries in publishing pharmacology, toxicology and pharmaceutics research papers
17
[Practice Examples of Academic Detailing -Prescription Support Based on Basic Pharmaceutical Science and Evidence].
18
Voltammetric Analysis of Cephalexin and Cefazoline in Pharmaceutical Formulation and Biological Samples
19
Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects
20
Development and validation of an ecofriendly chemiluminescence method for the determination of citalopram in pharmaceutical preparations using Cu²+-grafted Oxidized multiwall carbon nanotubes
21
Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases.
22
From courts to markets: New evidence on enforcement of pharmaceutical bans in India.
23
Human health risk assessment of pharmaceuticals in treated wastewater reused for non-potable applications in Sharjah, United Arab Emirates.
24
An Exploration of Factors Affecting Deposition of Pharmaceutical Aerosols in the Alberta Idealized Throat.
25
Home treatment and use of informal market of pharmaceutical drugs for the management of paediatric malaria in Cotonou, Benin.
26
Application of the Discrete Element Method for Manufacturing Process Simulation in the Pharmaceutical Industry.
27
Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016.
28
Mechanisms of pharmaceutical and personal care product removal in algae-based wastewater treatment systems.
29
Assessing the contribution of hydroxylation species in the photochemical transformation of primidone (pharmaceutical).
30
A proposal for an alternative approach to particle size method development during early stage small molecule pharmaceutical development.
31
Pharmaceutical Pill Counting and Inspection Using a Capacitive Sensor
32
Seasonal and spatial variations of pharmaceuticals and personal care products occurrence and human health risk in drinking water - A case study of China.
33
Concurrence of antibiotic resistant bacteria (ARB), viruses, pharmaceuticals and personal care products (PPCPs) in ambient waters of Guwahati, India: Urban vulnerability and resilience perspective.
34
An evaluation on the intra-day dynamics, seasonal variations and removal of selected pharmaceuticals and personal care products from urban wastewater treatment plants
35
Varying results of early benefit assessment of newly approved pharmaceutical drugs in Germany from 2011 to 2017: A study based on federal joint committee data.
36
The structure of the pharmaceutical market in Iran using concentration indices.
37
Direct UV photolysis of pharmaceutical compounds: Determination of pH-dependent quantum yield and full-scale performance
38
Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications
39
Chitosan Modification and Pharmaceutical/Biomedical Applications
40
Molecular, Cellular and Pharmaceutical Aspects of Biomaterials in Dentistry and Oral and Maxillofacial Surgery. An Internationalization of Higher Education and Research Perspective.
41
Patent implications in the pharmaceutical industry: Are static high prices leading to dynamic innovations?
42
Stone cutting industry waste-supported zinc oxide nanostructures for ultrasonic assisted decomposition of an anti-inflammatory non-steroidal pharmaceutical compound.
43
A novel enzymatic microreactor: Towards transforming the pharmaceutical industry
44
Toxicity of azo dyes in pharmaceutical industry
45
Role of Robotic Process Automation in Pharmaceutical Industries
46
Bioconjugation as a smart immobilization approach for α-amylase enzyme using stimuli-responsive Eudragit-L100 polymer: a robust biocatalyst for applications in pharmaceutical industry
47
Strategy-making process and firm performance in Iranian pharmaceutical industry
48
Evaluation of a Dry Coating Technology as a Substitute for Roller Compaction for Dry Agglomeration Applications in the Pharmaceutical Industry
49
The Contact-Hitting R&D Strategy of Family Firms in the Japanese Pharmaceutical Industry
50
Evaluation of pharmaceutical industry-led access programmes: A standardised framework
51
Microfluidic process intensification for synthesis and formulation in the pharmaceutical industry
52
Knowledge breadth and depth development through successful R&D alliance portfolio configuration: An empirical investigation in the pharmaceutical industry
53
From small molecule generics to biosimilars: Technological upgrading and patterns of distinctive learning processes in the Indian pharmaceutical industry
54
Stock market behavior of pharmaceutical industry in Iran and macroeconomic factors
55
Political connections and strategic choices of emerging market firms: Case study of Russia’s pharmaceutical industry
56
Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia's private healthcare sector
57
Determinants of intra-industry trade in pharmaceutical industry products. The case of the Czech republic and its eu trade partners
58
Response of safety pharmacologists to challenges arising from the rapidly evolving changes in the pharmaceutical industry
59
Modeling and Growth Kinetics of Antisolvent Crystallization Applied to the Pharmaceutical Industry
60
Health Technology Assessment in Japan: A Pharmaceutical Industry Perspective
61
Green Chemistry Articles of Interest to the Pharmaceutical Industry
62
Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
63
Analysis of energy-related CO <inf>2</inf> emissions in China's pharmaceutical industry and its driving forces
64
A qualitative approach to assess innovation in small infant industries within developing countries: The case of pharmaceuticals in Tunisia<sup>†</sup>
65
Does CSR matter in the pharmaceutical distribution industry?: The balanced scorecard perspective
66
When risks need attention: adoption of green supply chain initiatives in the pharmaceutical industry
67
Issues to consider in the pharmaceutical development of a cardiovascular polypill.
68
Are traditional small-scale screening methods reliable to predict pharmaceutical spray drying?
69
Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK.
70
Pharmaceuticals and Medical Devices: Business Practices.
71
The removal of pharmaceuticals during wastewater treatment: Can it be predicted accurately?
72
Two Manganese Peroxidases and a Laccase of KU-RNW027 with Novel Properties for Dye and Pharmaceutical Product Degradation in Redox Mediator-Free System.
73
Unveiling of Concealed Processes for the Degradation of Pharmaceutical Compounds by sp.
74
Characterization of recombinant laccase from Trametes versicolor synthesized by Arxula adeninivorans and its application in the degradation of pharmaceuticals
75
In silico Analysis for Laccase-mediated Bioremediation of the Emerging Pharmaceutical Pollutants
76
Bioaccumulation behaviour of pharmaceuticals and personal care products in a constructed wetland.
77
Novel Magnetic Carbon Nanotube-TiO <inf>2</inf> Composites for Solar Light Photocatalytic Degradation of Pharmaceuticals in the Presence of Natural Organic Matter
78
Adsorptive potential of tassel activated carbon towards the removal of metformin hydrochloride from pharmaceutical effluent.
79
Postgraduate Education in Pharmaceutical Medicine in Australia: Evaluation and Evolution to a Global Program Over 20 Years.
80
Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing.
81
A review of the effect of pharmaceutical firm drug announcements on stock option pricing.
82
The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6.
83
Synergistic catalytic effect between ultrasound waves and pyrimidine-2,4-diamine-functionalized magnetic nanoparticles: Applied for synthesis of 1,4-dihydropyridine pharmaceutical derivatives.
84
Trends in heroin and pharmaceutical-opioid related harms in Victoria, Australia up to 2018.
85
Analysis of pharmaceutical impurities using multi-heartcutting 2D LC coupled with UV-charged aerosol MS detection.
86
Consumer behaviour towards pharmaceutical products: a model development
87
The impact of evidence from clinical trials on counselling for over-the-counter drugs: A national survey of pharmaceutical staff in German pharmacies.
88
A Comparative Study on Different Pharmaceutical Industries and Proposing a Model for the Context of Iran.
89
The impact of pharmaceutical marketing on market access, treatment coverage, pricing, and social welfare
90
Proceed to the innovation in the pharmaceutical industry. The case of Spain
91
Assessing Biopharmaceutical Company Experience with Patient-centric Initiatives.
92
Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.
93
First nationwide investigation and environmental risk assessment of 72 pharmaceuticals and personal care products from Sri Lankan surface waterways.
94
Spectrophotometric determination of tranexamic acid in pharmaceutical bulk and dosage forms.
95
Simple spectrofluorimetric methods for determination of veterinary antibiotic drug (apramycin sulfate) in pharmaceutical preparations and milk samples
96
Pharmaceutical diversification via palladium oxidative addition complexes.
97
Development of a highly efficient decontamination approach for ceftolozane in the pharmaceutical manufacturing environment.
98
PLANTAGO OVATA: A COMPREHENSIVE REVIEW ON CULTIVATION, BIOCHEMICAL, PHARMACEUTICAL AND PHARMACOLOGICAL ASPECTS.
99
Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
100
A novel pharmaceutical excipient: Coprecipitation of calcium and magnesium silicate using brine-seawater in date palm cellulose as an absorbing host
101
A novel pharmaceutical excipient: Coprecipitation of calcium and magnesium silicate using brine-seawater in date palm cellulose as an absorbing host